Coenzyme A Net Income
| PPII Stock | USD 0.0002 0.00 0.00% |
In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Coenzyme A, as well as the relationship between them.
Coenzyme A Total Revenue |
|
Gross Profit | Market Capitalization 111 | Revenue | Earnings Share (35.31) | Quarterly Revenue Growth 0.268 |
| Last Reported | Projected for Next Year | ||
| Net Loss | -139.3 K | -146.3 K | |
| Net Loss | -139.3 K | -146.3 K | |
| Net Loss | -139.3 K | -146.3 K |
Coenzyme | Net Income | Build AI portfolio with Coenzyme Stock |
The Net Income trend for Coenzyme A offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Coenzyme A is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Coenzyme A's Net Income Growth Pattern
Below is the plot of the Net Income of Coenzyme A over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Coenzyme A financial statement analysis. It represents the amount of money remaining after all of Coenzyme A operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Coenzyme A's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Coenzyme A's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (154.78 K) | 10 Years Trend |
|
Net Income |
| Timeline |
Coenzyme Net Income Regression Statistics
| Arithmetic Mean | (149,411) | |
| Coefficient Of Variation | (11.03) | |
| Mean Deviation | 8,843 | |
| Median | (154,780) | |
| Standard Deviation | 16,487 | |
| Sample Variance | 271.8M | |
| Range | 67.3K | |
| R-Value | (0.27) | |
| Mean Square Error | 268.6M | |
| R-Squared | 0.07 | |
| Significance | 0.29 | |
| Slope | (886.86) | |
| Total Sum of Squares | 4.3B |
Coenzyme Net Income History
Other Fundumenentals of Coenzyme A
Coenzyme A Net Income component correlations
Click cells to compare fundamentals
Is there potential for Pharmaceuticals market expansion? Will Coenzyme introduce new products? Factors like these will boost the valuation of Coenzyme A. Anticipated expansion of Coenzyme directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Coenzyme A listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (35.31) | Revenue Per Share 2.652 | Quarterly Revenue Growth 0.268 |
Coenzyme A's market price often diverges from its book value, the accounting figure shown on Coenzyme's balance sheet. Smart investors calculate Coenzyme A's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Coenzyme A's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Coenzyme A's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Coenzyme A should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Coenzyme A's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Coenzyme A 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Coenzyme A's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Coenzyme A.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Coenzyme A on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Coenzyme A or generate 0.0% return on investment in Coenzyme A over 90 days. Coenzyme-A Inc. formulates and manufactures nutraceutical supplements, and skin and hair care products in the United Sta... More
Coenzyme A Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Coenzyme A's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Coenzyme A upside and downside potential and time the market with a certain degree of confidence.
Coenzyme A Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Coenzyme A's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Coenzyme A's standard deviation. In reality, there are many statistical measures that can use Coenzyme A historical prices to predict the future Coenzyme A's volatility.Coenzyme A Backtested Returns
We have found three technical indicators for Coenzyme A, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Coenzyme A are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Coenzyme A has perfect predictability. Overlapping area represents the amount of predictability between Coenzyme A time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Coenzyme A price movement. The serial correlation of 1.0 indicates that 100.0% of current Coenzyme A price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Coenzyme Operating Income
Operating Income |
|
Based on the recorded statements, Coenzyme A reported net income of (154,780). This is 100.05% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 100.03% higher than that of the company.
Coenzyme Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Coenzyme A's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Coenzyme A could also be used in its relative valuation, which is a method of valuing Coenzyme A by comparing valuation metrics of similar companies.Coenzyme A is currently under evaluation in net income category among its peers.
Coenzyme Fundamentals
| Operating Margin | (34.92) % | ||||
| Current Valuation | 397.18 K | ||||
| Shares Outstanding | 555.05 K | ||||
| Price To Sales | 0.0003 X | ||||
| Revenue | 325.46 K | ||||
| Gross Profit | 228.56 K | ||||
| EBITDA | (4.54 M) | ||||
| Net Income | (154.78 K) | ||||
| Cash And Equivalents | 35.53 K | ||||
| Cash Per Share | 0.07 X | ||||
| Total Debt | 419.28 K | ||||
| Current Ratio | 0.16 X | ||||
| Book Value Per Share | (1.14) X | ||||
| Cash Flow From Operations | (4 K) | ||||
| Earnings Per Share | (35.31) X | ||||
| Beta | 1.56 | ||||
| Market Capitalization | 111 | ||||
| Total Asset | 79.08 K | ||||
| Retained Earnings | (742.76 K) | ||||
| Net Asset | 79.08 K |
About Coenzyme A Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Coenzyme A's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coenzyme A using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coenzyme A based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Check out For more detail on how to invest in Coenzyme Stock please use our How to Invest in Coenzyme A guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is there potential for Pharmaceuticals market expansion? Will Coenzyme introduce new products? Factors like these will boost the valuation of Coenzyme A. Anticipated expansion of Coenzyme directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Coenzyme A listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (35.31) | Revenue Per Share 2.652 | Quarterly Revenue Growth 0.268 |
Coenzyme A's market price often diverges from its book value, the accounting figure shown on Coenzyme's balance sheet. Smart investors calculate Coenzyme A's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Coenzyme A's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Coenzyme A's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Coenzyme A should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Coenzyme A's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.